InvestorsHub Logo

gew59

11/12/20 2:17 PM

#34470 RE: jfkspire #34469

INO-4800 has a long way to go before it can be called a vaccine. Kim is redoubling efforts now though. That should make for fewer delays.

MiamiGent

11/12/20 4:44 PM

#34480 RE: jfkspire #34469

INO Inovio does not have a vaccine, percival. It has a "construct", a "candidate". Just as it has had constructs for other epidemics over the years with not one working out. Not even completing a single successful Phase Three Trial- in its forty one (41) years of corporate existence!

Inovio is in the stock printing business. It's a recognized maven of world wide pumping.

Newbees stay away from INO. It's quicksand to your dollars. Bagholders are legion, here. Many have died waiting in vain.

MG
Father of The Inovio Expose
No position whatsoever, in about five years

Tamtam

11/13/20 2:48 PM

#34513 RE: jfkspire #34469

Great post Percival, there's so must trust in this company by it's partners and funded by an international alliance of public, private companies, and inter- and non-governmental charities. Those people know what INO does.
I'm sure newbies take all this into account and will act accordingly. Shorts will be burned heavily.

-FIRST Lassa fever vaccine to enter clinic (INO-4500), funded by CEPI

-FIRST MERS vaccine to progress to Phase 2 clinical testing (INO-4700), funded by CEPI

-FIRST dMAb™ plasmid in Phase 1 for Zika (INO-A002), funded by Bill & Melinda Gates Foundation